Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 18 of 98, showing 5 Applications out of 488 total, starting on record 86, ending on 90

# Protocol No Study Title Investigator(s) & Site(s)

86.

ECCT/23/10/07   Fermented Food and Prediabetes
        A Study of the Hypoglycemic Effect of African Traditonal Fermented Foods amongst Prediabetic Adults.   
Principal Investigator(s)
1. Rosebella Iseme - Ondiek
Site(s) in Kenya
1. Aga Khan Outreach Centre Nairobi CBD/Town (Nairobi City county)
2. Aga Khan Outreach Centre Valley Arcade (Nairobi City county)
3. Aga Khan Outreach Centre Capital Centre (Nairobi City county)
4. Aga Khan Outreach Centre Kiambu Town (Kiambu county)
5. Aga Khan Outreach Centre Juja (Kiambu county)
6. Aga Khan Outreach Centre Ruiru (Kiambu county)
7. Aga Khan Outreach Centre Ongata Rongai (Kajiado county)
8. Aga Khan Outreach Centre Ngong (Kajiado county)
9. Aga Khan Outreach Centre Kitengela (Kajiado county)
 
View

87.

ECCT/23/05/08   ACTIV-2d/A5407
    A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19    
Principal Investigator(s)
1. Dr John Kinuthia
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. Victoria Biomedical Research Institute, (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
4. KEMRI CCR – BUTERE SITE (Kakamega county)
5. Kenya Medical Research Institute/Walter Reed Project (Kericho county)
6. KEMRI – AHERO Clinical Trials Unit (Kisumu county)
 
View

88.

ECCT/23/04/05   BiMVaC01
    A randomised, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of the bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 vaccine formulations in healthy unvaccinated East African adults.   
Principal Investigator(s)
1. NDUNGU FRANCIS
2. Said Jongo
Site(s) in Kenya
KEMRI-CGMRC Kilifi
 
View

89.

ECCT/23/04/03   ACTIV-2d/A5407
    A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19   
Principal Investigator(s)
1. Prof Abraham Mosigisi Siika
Site(s) in Kenya
1. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (Uasin Gishu county)
2. Victoria Biomedical Research Institute, (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
4. KEMRI CCR – BUTERE SITE (Kakamega county)
5. Kenya Medical Research Institute/Walter Reed Project (Kericho county)
6. KEMRI – AHERO Clinical Trials Units (Kisumu county)
 
View

90.

ECCT/23/05/03   BrainCapture EEG Validation
          Usability and efficacy of an affordable, smartphone-connected EEG device to bridge the global gap in epilepsy diagnosis             
Principal Investigator(s)
1. Diraj Sokhi Sokhi
Site(s) in Kenya
Aga Khan University Hospital Nairobi
 
View